O rgan transplantation (Tx)
3 results in a transfer of leukocytes present in the graft into the recipient. The migration of donor cells to host tissues results in chimerism and this response has been proposed to be associated with donorspecific tolerance (1, 2) . The relevance of these passenger leukocytes in Tx outcome has been demonstrated in several models showing significant roles in regulation of immune reactions after organ Tx. In a heart Tx model, selective Ab-mediated depletion of donor leukocytes leads to the prevention of tolerance induction and is associated with severe acute or chronic graft rejection (3) . Similar results have been found in experimental liver Tx, in which depletion of passenger leukocytes leads to rejection of the graft in spontaneously tolerant recipients (4, 5) . Reconstitution of donor leukocytes by i.v. injection recovers graft acceptance. Part of this recovery has been shown to be dependant on T cells, but not B cells or monocytes/macrophages, as shown by selective deletion from the reconstituting donor leukocytes (6, 7) . However, the exact mechanism of this so-called chimerism-associated tolerance remains unclear. It has been suggested that high levels of chimerism, like for instance following bone marrow Tx after myeloablation, are associated with tolerance through clonal deletion or anergy induction of host T cells. Low levels of chimerism, such as following solid organ Tx, are associated with tolerance through regulatory mechanisms that may involve active suppression of alloresponses by regulatory T cells (Tregs) (8, 9) . Both in clinical and experimental Tx, chimerism and chimerism-associated tolerance are more frequently seen with liver compared with other organ Tx (10, 11) . Higher levels of chimerism in liver Tx are associated with reduced incidences of acute rejection and better initial graft acceptance (12) .
Within the regulatory cell populations, CD4 ϩ CD25 ϩ Tregs play a critical role in various models of transplant tolerance (13) (14) (15) (16) . Regulation of alloresponses seems to depend in part on CTLA-4, which is constitutively expressed by Tregs (17, 18) . Bigenzahn et al. (19) showed that depletion of CD25 ϩ cells shortly after nonmyeloablative bone marrow Tx and costimulation blockade significantly reduced tolerance induction. This finding suggests that CD4 ϩ CD25 ϩ Tregs may be actively involved in chimerism-associated tolerance, particularly early after Tx. However, this involvement remains controversial because other studies did not confirm a role for CD4 ϩ CD25 ϩ Tregs after bone marrow Tx (20, 21) . To determine the specific role of donor leukocytes in the outcome of solid organ Tx, it is important to phenotypically (22) and functionally characterize donor-derived leukocytes. In clinical liver Tx, the effluent solution passing through the graft livers during perfusion before Tx has been shown to be useful for this purpose. The leukocytes isolated from this perfusate solution represent detached liver-associated leukocytes, as shown by increased proportion of CD8 ϩ cells that outnumber CD4 ϩ cells and high NK cell numbers comparable with cell numbers in liver tissue (23, 24) . Furthermore, the myeloid dendritic cell (DC) population present in the perfusates has an immature phenotype identical with DC isolated from liver tissue and produced higher amounts of IL-10 compared with blood DC (24) .
In the current study, we determined the migration and suppressive capacity of donor CD4 ϩ CD25 ϩ Tregs transferred from the liver graft into the perfusate and the recipient after Tx. We show that the lymphocyte population that migrates from the human liver is enriched for CD4 ϩ CD25 ϩ forkhead box p3 (Foxp3) ϩ cells and that these cells suppress proliferation and IFN-␥ production of recipient T cells in vitro. In addition, we demonstrate that donor-derived cells with a regulatory phenotype can be detected in substantial numbers in the circulation of recipients after liver Tx.
Materials and Methods

Perfusate and PBMC collection
Liver perfusates were collected from 22 human liver grafts. During the backtable procedure, the grafts were perfused through the portal vein with 1-2 L of University of Wisconsin solution to remove residual blood from the vasculature. Immediately before Tx, the donor liver was perfused with 200 up to 500 ml of human albumin solution under hydrostatic pressure, and the perfusate was collected from the vena cava. Mononuclear cells from perfusate were isolated within 12 h by density gradient centrifugation using Ficoll Paque Plus (Amersham Biosciences). PBMC were obtained from healthy volunteers (n ϭ 14), which served as control. After isolation, cells were stored in 10% DMSO-containing medium at Ϫ180°C. From six HLA-A2-negative liver recipients who received an HLA-A2-positive graft, blood samples were taken before and during the first weeks after Tx. From five liver transplant recipients, peripheral blood was collected pre-Tx for functional assays. This study was approved by the Medical Ethical Committee of the Erasmus MC, and informed consent was obtained from all participants.
mAbs
The following fluorochrome-conjugated mAbs were used: CD25-allophycocyanin, CD4-PerCP Cy5.5, IgG1-FITC, and IgG1-allophycocyanin from BD Biosciences; CTLA-4-PE, CD3-FITC, CD3-PE, and IgG2a-PE from Immunotech; Foxp3-allophycocyanin, CD127-FITC, and isotype IgG2a-allophycocyanin from eBioscience; CD11a from BioSource International; and secondary Ab (goat anti-mouse) FITC, CD8-allophycocyanin, and CD4-allophycocyanin from DakoCytomation. HLA-A2 staining was performed with an anti-HLA-A2 Ab derived from a hybridoma (clone BB7.2, no. HB-82; American Type Culture Collection) followed by an FITC-conjugated rabbit anti-mouse IgG secondary Ab (DakoCytomation).
Flow cytometric analysis
After thawing, liver perfusate mononuclear cells (LPMC) and PBMC were washed twice with PBS containing 0.3% BSA followed by staining with primary mAbs CD3, CD4, CD8, CD25, and CD127 in PBS/0.3% BSA (30 min at 4°C). Following primary incubation, cells were washed, and for staining of intracellular CTLA-4 or Foxp3, the cells were fixed and permeabilized using the IntraPrep Reagents (Immunotech) or fixation/permeabilization agents supplied by eBioscience, respectively. HLA-A2-positive cells were determined by incubation with anti-HLA-A2 Ab followed by staining with FITC-conjugated anti-mouse IgG. Expression of LFA-1 (CD11a) was determined in a similar manner by primary staining for CD11a followed by secondary staining with FITC-conjugated anti-mouse IgG. Flow cytometric analysis was performed using FACSCalibur and CellQuest Pro software (BD Biosciences).
CD4
ϩ CD25 ϩ T cell isolation CD4 ϩ cells were purified from fresh LPMC and PBMC using the untouched CD4 ϩ T cell isolation kit (Miltenyi Biotec). After washing with PBS/0.3% BSA, CD4
ϩ T cells were incubated with anti-CD25 microbeads (Miltenyi Biotec) followed by a positive selection of CD4 ϩ CD25 ϩ T cells, according to the manufacturer's instructions. The CD4 ϩ CD25 Ϫ fraction was used as responder cells. The purified Treg fraction contained Ͼ90% pure CD4
ϩ CD25 ϩ T cells. 10% pooled heat-inactivated human serum, 100 IU/ml penicillin, and 100 g/ml streptomycin in a total volume of 200 l. To determine the suppressive activity of CD4 ϩ CD25 ϩ T cells isolated from LPMC and PBMC, increasing numbers of CD4 ϩ CD25 ϩ T cells (1.0 and 3.0 ϫ 10 4 ) were added to the cultures. Cultures were performed in duplicate or triplicate. At day 4 of culture, 100 l of culture medium was replaced, and the concentration of IFN-␥ was measured by ELISA (U-CyTech). After 5 days, T cell divisions were analyzed by flow cytometry by staining the cells with CD3 and CD4 Abs. CFSE flow cytometry data were analyzed by ModFit software version 3.0 (Verity Software House). The proliferation index, which is the sum of the cells in all generations divided by the computed number of original parent cells, indicates the extent of T cell expansion. If the proliferation index is equal to one, than no T cell division took place during the course of the culture.
MLR and suppressor activity assays
Statistical analysis
For the MLR and IFN-␥ production, statistical analysis was performed by analysis of the logarithmic transformation of the dependent variable with random intercept and random slope using PROC Mixed in SAS version 9.1 (SAS Institute). Significant differences between LPMC and PBMC flow cytometric results were determined with the Mann-Whitney U test using SPSS software version 11.0.
Results
LPMC are of liver origin
Perfusates were collected during the pre-Tx albumin perfusion of donor livers on the bench. With a mean ischemia time of 7 Ϯ 2 h, the perfusates contained on average 91 ϫ 10 6 mononuclear cells (10 -500 ϫ 10 6 ). Viability as determined by trypan blue exclusion showed that 98 Ϯ 2% of the LPMC were vital. Liver lymphocytes are known to express higher levels of LFA-1 than lymphocytes in peripheral blood (25, 26) . Flow cytometric characterization of LPMC and PBMC showed that within the perfusates, a significantly greater proportion of lymphocytes had high LFA-1 expression (Fig. 1) . The CD4 to CD8 ratio in perfusates was 1:2.4 (n ϭ 22 human liver grafts) and was significantly distinct from the 2:1 ratio in blood from controls (n ϭ 14; p Ͻ 0.001). These findings indicate that leukocytes present in perfusates are predominantly liver derived and not derived from residual blood. 
LPMC are enriched for CD4
ϩ CD25 ϩ CTLA4 ϩ and
To determine the presence of T cells with regulatory phenotype, CD25, CTLA-4, and Foxp3 expression within CD3 ϩ CD4 ϩ T cells was assessed by flow cytometry. Fig. 2A is a FACS 
CD25
ϩ Foxp3 ϩ T cells in perfusates (Fig. 3B) . RT-PCR confirmed the presence of Foxp3 ϩ T cells by analysis of FOXP3 transcript levels in perfusates (data not shown). Analysis of CD127, the IL-7R, showed that the majority of perfusate Foxp3 ϩ cells were negative for CD127 identical with Foxp3 ϩ cells in blood (Fig. 3, C and D) . In sum, these data indicate that a considerable proportion of Th cells that detach from the liver during perfusion have a regulatory phenotype.
Perfusate CD4 ϩ CD25 ϩ T cells inhibit proliferation and IFN-␥ production of donor and recipient responder T cells
To test the suppressive activity of CD4 ϩ CD25 ϩ T cells in LPMC, we performed MLR analysis using CFSE fluorescent-labeled responder T cells. First, we tested the suppressive activity of ϩ cells and within CD4 ϩ CD25 ϩ CTLA4 ϩ cells is highest at 1 wk (n ϭ 6) and gradually decreases at 1 mo (n ϭ 4) and 6 mo (n ϭ 4) after Tx. C, At 1 wk and 6 mo after Tx, the proportion of donor CD4 ϩ CD25 Ϫ responder cells, we observed significant suppression of proliferation comparable to the inhibition observed in the autologous setting (Fig. 4) . Consistently, when looking at the IFN-␥ production in these MLR analyses, similar results were found showing dose-dependent inhibition by donor CD4 ϩ CD25 ϩ T cells of donor and recipient IFN-␥ production (Fig. 5) . The suppression of both proliferation and IFN-␥ production suggests that CD4 ϩ CD25 ϩ T cells from the liver are able to suppress the direct pathway alloresponse in vitro.
cells detach from the liver graft after Tx and circulate in recipients
To determine whether donor T cells with a regulatory phenotype can be detected in recipients after liver Tx, we performed flow cytometric analysis of PBMC from HLA-A2-negative recipients who received an HLA-A2-positive liver graft. Determination of HLA-A2 class 1 allele has previously been shown to be useful to distinguish between donor and recipients cells (27, 28) . A representative staining is shown in Fig. 6A . In the first week after Tx, 3.1 Ϯ 1.0% (ϮSEM) of the total CD4 ϩ T cells and 2.5 Ϯ 1.0% (ϮSEM) of the CD4 ϩ CD25 ϩ CTLA4 ϩ cells were found to be of donor origin (Fig. 6B) . These percentages of donor cells increased initially and gradually declined at 1 and 6 mo after Tx. Similar results were found when analyzing the percentage of HLA-A2-positive cells within the CD4 ϩ CD25 ϩ Foxp3 ϩ fraction (n ϭ 4; data not shown). The proportion of CD25 ϩ CTLA4 ϩ cells within CD4 ϩ cells was significantly higher in donor-derived than in recipient cells (Fig. 6C) . There was also a difference at 6 mo, although the overall percentage of CD4 ϩ CD25 ϩ CTLA4 ϩ cells had declined at this time point. These data indicate that donor T cells with a regulatory phenotype migrate from the liver graft into the circulation of recipients.
Discussion
The unique immunological properties of the liver have partly been attributed to the resident leukocyte population. Following liver Tx, donor leukocytes present in the graft are transferred and persist in recipients, a condition referred to as chimerism. In this study we aimed to investigate the presence of Tregs in liver graft perfusion solution and in recipient blood after Tx. Within perfusate CD3 ϩ CD4 ϩ T cells an increased proportion of CD25 ϩ CTLA4 ϩ and CD25 ϩ Foxp3 ϩ T cells were found as compared with cells found in peripheral blood of healthy controls (Figs. 2 and 3) . FOXP3 mRNA expression in LPMC confirmed the presence of Treg (data not shown). Leukocytes in recipient circulation were shown to contain substantial numbers of donor CD4
ϩ T cells indicative of a regulatory signature (Fig. 6 ). The functionality of donor Treg was studied in MLR, showing inhibition of proliferation of self-and recipient-responder CD4 ϩ CD25
Ϫ T cells upon stimulation with donor and recipient mononuclear cells (Fig. 4) . Furthermore, the cytokine production was significantly inhibited, confirming the suppressive activity of CD4 ϩ CD25 ϩ T cells within the LPMC (Fig. 5) . The number of mononuclear cells obtained from perfusates showed a wide range, but did not correlate with ischemia time or perfusate volume (data not shown). Immunophenotypic characterization of LPMC shows clear differences when compared with PBMC, yet comparable with leukocyte subsets obtained from liver tissue (23, 24) . Our results show significantly lower proportions of CD4 ϩ T cells and higher proportions of CD8 ϩ within total LPMC T cell population compared with proportions found in peripheral blood. Previously, it was shown that liver-infiltrating T cells have high expression levels of the ␤ 2 integrin LFA-1 (22, 25) . Therefore we determined the expression of LFA-1 ␣-chain (CD11a), which is expressed exclusively on leukocytes and is involved in migration into tissues. The CD4 ϩ T cells in perfusates have a strong LFA-1 expression, which is significantly higher compared with CD4 ϩ T cells in PBMC (Fig. 1) . The strong adhesion molecule expression and the reversed CD4 to CD8 ratio indicate that these cells originate from the liver tissue and have a preactivated phenotype (22, 29) .
Within the CD4 ϩ T cell population obtained from perfusates, a considerable proportion of T cells with a regulatory phenotype was observed. Tregs characterized by CD4, CD25, CTLA-4, and Foxp3 expression were significantly increased compared with peripheral blood levels in healthy controls (Figs. 2 and 3) . Recently, the absence of the IL-7R CD127 expression has been suggested as a discriminating factor of Foxp3 ϩ Treg (30, 31) . Our analysis showed that the majority of liver-derived Foxp3 ϩ cells were CD127-negative, which was comparable to cells in control blood (Fig. 3D) . To our knowledge, this study is the first to show the presence of CD4 ϩ CD25 ϩ Foxp3 ϩ T cells as passenger leukocytes in liver grafts. Following liver Tx, a substantial proportion of circulating leukocytes is of donor origin (28) and even higher in the case of graft-vs-host disease (32) . In the first week after Tx, we have shown that up to 5% of the total CD4 ϩ CD25 ϩ CTLA4 ϩ T cell population were of donor origin (Fig. 6B) , equivalent to ϳ5-15 ϫ 10 6 cells. The proportion of CD4 ϩ cells that expressed CD25 and CTLA-4 was higher in donor cells than in recipient cells at 1 and 6 mo after Tx (Fig. 6C) . Both donor and recipient CD4 ϩ CD25 ϩ CTLA4 ϩ cells decreased in time after Tx. This general drop of CD4 ϩ CD25 ϩ CTLA4 ϩ Tregs was consistent with our previous studies (33, 34) . Katz et al. (35) have shown that hepatic CD4 ϩ T cells are functionally suppressed by environmental factors, which may explain the low proliferative capacity of CD4 ϩ CD25 Ϫ responder cells from LPMC in our study. As we have shown that a relatively increased proportion of CD4 ϩ T cells present in the liver have a regulatory phenotype, one might postulate that hepatic Tregs are involved in mediating suppression of responses to Ags presented in the liver. In the context of Tx, these hepatic Tregs may suppress not only alloantigen-specific recipient T cells but also DC and thereby inhibit the immune response against the graft. In our previous study we have shown that hepatic DC have an immature phenotype and produce high amounts of IL-10 (24). Experimental evidence suggests that immature DC can mediate tolerance, presumably by the induction of Tregs (36, 37) . Furthermore, in vitro, immature DC can induce alloantigen-reactive Tregs (38) . Liverderived DC are able to down-regulate immune responses and stimulate T cells to produce IL-10 and IL-4 (39 -41). However, Tregs limit the ability of DC to stimulate T cells and enhance the ability of DC to induce anergy concomitant with an increase in CTLA-4 expression (42) (43) (44) . This way, a bidirectional interaction may occur between liver T cells and DC, which may explain the unique hepatic microenvironment that is known to promote tolerance.
In this study we have shown that donor CD4 ϩ CD25 ϩ T cells originating from the liver graft are able to suppress responder T cells from both recipient and donor. This observation suggests that Tregs can suppress across a MHC barrier. This work is consistent with previous findings showing that Tregs suppress Ag nonspecifically once activated through their TCR (45) . Furthermore, recently it was shown that allogeneic Treg can inhibit MHC-disparate responder T cells (46) . These data indicate that chimerism of donor Treg may contribute to suppression of the direct pathway alloresponse that is the dominant Ag presentation pathway driving rejection early after Tx. The immunological relevance of donor leukocytes for allograft acceptance is particularly evident during the early phase after Tx (3). As we have shown that CD4 ϩ CD25 ϩ T cells are functional in suppressing responder cells, one might postulate that these cells participate in the silencing of donor reactive T cells. These findings fit with the possibility that chimerism plays a key role in acquired Tx tolerance. Donor leukocyte migration and chimerism are associated with transplant tolerance in both the clinical and experimental setting (1, 2, 47) . Depletion of donor leukocytes or failure to develop chimerism was shown to result in prompt rejection, but chimerism by itself is not sufficient to prevent rejection. In clinical Tx, the beneficial effect of donor leukocytes was clearly shown by pre-Tx blood transfusions leading to enhanced graft survival (48, 49) . It is evident that donor leukocytes are important during the first weeks post-Tx in which maximal donor migration and interaction with host leukocytes occur. The exact mechanism in achieving tolerance through chimerism, however, has not been elucidated. Several mechanisms have been proposed in this process including clonal exhaustion or deletion, T cell anergy, and active suppression (8, 10) . Although the cell interactions are indisputably complex, tolerance to skin transplants following bone marrow Tx was CD4 ϩ CD25 ϩ Treg-dependent mostly early after Tx (19) . Conversely, in bone marrow Tx, an important role for CD4 ϩ Tregs has recently been identified in the induction of chimerism-associated tolerance, which was CD25-independent but CTLA-4-dependent (20) . Whether graft-derived donor Tregs influence the balance between the immunogenicity and tolerogenicity of organ allografts remains to be determined.
In conclusion, a substantial number of donor Tregs detach from the liver graft during perfusion and continue to migrate into the recipient after Tx. These donor Tregs are functional in suppressing the direct pathway alloresponses in vitro and may therefore contribute to chimerism-associated tolerance early after liver Tx.
